文献速递肝病

妊娠期非酒精性脂肪性肝病与不良母儿结局相关

Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes.
PubMed 文献 · J Hepatol · 2020-06-09

基于美国全国住院患者样本的加权出院数据,分析妊娠20周后非酒精性脂肪性肝病(NAFLD)的患病趋势及结局。NAFLD患病率从2007年10.5/10万妊娠升至2015年28.9/10万(p<0.001),且与高血压并发症、产后出血和早产独立相关。NAFLD应被视为高危产科状况,需孕前咨询和孕期管理。

要点

  • 妊娠期NAFLD患病率从2007年10.5/10万升至2015年28.9/10万,几乎增至三倍(p<0.001)。
  • NAFLD组妊娠期糖尿病23%、高血压并发症16%、产后出血6%、早产9%,均高于其他慢性肝病或无慢性肝病组(p≤0.01)。
  • 调整分析显示NAFLD与高血压并发症、早产、产后出血及可能的母亲死亡(而非胎儿死亡)相关。

核心结论

  • 妊娠期NAFLD患病率在过去十年几乎增至三倍,且与高血压并发症、产后出血和早产独立相关。
  • NAFLD应被视为高危产科状况,对孕前咨询和孕期保健具有临床意义。

研究设计与样本

  • 研究采用美国全国住院患者样本的加权出院数据,评估妊娠20周后NAFLD的时间趋势,并与其它慢性肝病或无慢性肝病的妊娠比较结局。
  • 共纳入18,574,225例妊娠,其中5,640例有NAFLD,115,210例有其他非NAFLD慢性肝病。
  • 结局包括早产、产后出血、高血压并发症(子痫前期、子痫和/或HELLP综合征)及母亲或胎儿死亡。
  • NAFLD患病率按日历年估计,时间趋势用线性回归检验;结局用logistic回归分析,调整年龄、种族、多胎妊娠、孕前糖尿病、肥胖、血脂异常和高血压。

主要发现

  • NAFLD患病率从2007年10.5/10万妊娠升至2015年28.9/10万妊娠(p<0.001)。
  • NAFLD组妊娠期糖尿病为23%,其他组为7-8%;高血压并发症为16% vs 4%;产后出血为6% vs 3-5%;早产为9% vs 5-7%,所有p值≤0.01。
  • 调整分析中,与无慢性肝病相比,NAFLD与高血压并发症、早产、产后出血及可能的母亲死亡(而非胎儿死亡)相关。

临床怎么用

  • 作者认为NAFLD应被视为高危产科状况,对孕前咨询和孕期保健具有临床意义。
  • 作者指出对妊娠期NAFLD女性应进行孕前咨询,并考虑高危产科管理。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The prevalence of non-alcoholic fatty liver disease (NAFLD) is rising in young adults, with potential implications for reproductive-aged women. Whether NAFLD during pregnancy confers more serious risks for maternal or perinatal health is unclear. METHODS: Using weighted discharge data from the US national inpatient sample, we evaluated temporal trends of NAFLD in pregnancies after 20 weeks gestation, and compared outcomes to pregnancies with other chronic liver diseases (CLDs) or no CLD. Study outcomes included preterm birth, postpartum hemorrhage, hypertensive complications (pre-eclampsia, eclampsia, and/or hemolysis, elevated liver enzymes, and low platelets syndrome), and maternal or fetal death. NAFLD prevalence was estimated by calendar year and temporal trends tested by linear regression. Outcomes were analyzed by logistic regression adjusted for age, race, multiple gestation, and pre-pregnancy diabetes, obesity, dyslipidemia and hypertension. RESULTS: Among 18,574,225 pregnancies, 5,640 had NAFLD and 115,210 had other, non-NAFLD CLD. Pregnancies with NAFLD nearly tripled from 10.5/100,000 pregnancies in 2007 to 28.9/100,000 in 2015 (p <0.001). Compared to the other groups, patients with NAFLD during pregnancy more frequently experienced gestational diabetes (7-8% vs. 23%), hypertensive complications (4% vs. 16%), postpartum hemorrhage (3-5% vs. 6%), and preterm birth (5-7% vs. 9%), all p values ≤0.01. On adjusted analysis, compared to no CLD, NAFLD was associated with hypertensive complications, preterm birth, postpartum hemorrhage and possibly maternal (but not fetal) death. CONCLUSION: The prevalence of NAFLD in pregnancy has nearly tripled in the last decade and is independently associated with hypertensive complications, postpartum hemorrhage and preterm birth. NAFLD should be considered a high-risk obstetric condition, with clinical implications for pre-conception counseling and pregnancy care. LAY SUMMARY: The prevalence of non-alcoholic fatty liver disease (NAFLD) in pregnancy has almost tripled over the past 10 years. Having NAFLD during pregnancy increases risks for both the mother and the baby, including hypertensive complications of pregnancy, bleeding after delivery, and preterm birth. Thus, pre-conception counseling is warranted with consideration of high-risk obstetric management among women with NAFLD in pregnancy.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Sarkar M, Grab J, Dodge JL, et al. Non-alcoholic fatty liver disease in pregnancy is associated with adverse maternal and perinatal outcomes. J Hepatol. 2020. PMID: 32531415. doi:10.1016/j.jhep.2020.03.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。